Kiribati vs Vietnam: Tuberculosis treatment success rate (% of new cases)
Kiribati
89.0%
in 2023
Vietnam
89.0%
in 2023
Kiribati rank
58th
Vietnam rank
58th
Tuberculosis treatment success rate (% of new cases) over time
- Kiribati
- Vietnam
How they compare
Kiribati currently reports 89.0% against 89.0% in Vietnam, a difference of 0.0%.
The two have swapped places 6 times across 24 shared years of data; in 2000 it was Vietnam ahead.
Kiribati ranks 58th and Vietnam ranks 58th of 203 countries.
Vietnam has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | Kiribati | Vietnam | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 89.4% | 92.0% | 2.6% | Vietnam |
| 2010s | 89.7% | 91.4% | 1.7% | Vietnam |
| 2020s | 86.0% | 89.8% | 3.8% | Vietnam |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher tuberculosis treatment success rate, Kiribati or Vietnam?
- Kiribati, at 89.0% against 89.0% in Vietnam as of 2023.
- What is the difference in tuberculosis treatment success rate between Kiribati and Vietnam?
- 0.0%, with Kiribati ahead.
- How many years of comparable data are there for Kiribati and Vietnam?
- 24 years are reported by both, from 2000 to 2023.
- How do Kiribati and Vietnam rank globally for tuberculosis treatment success rate?
- Kiribati ranks 58th and Vietnam ranks 58th of 203 countries.
- Where does this data come from?
- Global Tuberculosis Report, World Health Organization (WHO), published as Tuberculosis treatment success rate (% of new cases). Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Tuberculosis treatment success rate is the percentage of all new tuberculosis cases (or new and relapse cases for some countries) registered under a national tuberculosis control programme in a given year that successfully completed treatment, with or without bacteriological evidence of success ("cured" and "treatment completed" respectively).